Drugs / KL130008
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05496426 | Nov 2022 → Apr 2024 | alopecia areata | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KL130008 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05496426 ↗ |
| Route | Oral | “KL130008 capsule administered orally” NCT05496426 ↗ |